LeMaitre Vascular, Inc. (LMAT) Q3 2021 Earnings Results

Lemaitre Vascular Misses on EPS, Stock Up 2.48%

The earnings report shows that Lemaitre Vascular's EPS fell short of expectations, which may raise concerns among investors. However, the stock reacted positively, increasing by 2.48%, likely due to management's optimistic outlook on long-term growth despite current challenges. Investors may be encouraged by the strong demand for their products.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.30	N/A	-9.09%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the future. They acknowledged the current challenges but emphasized their commitment to growth.

Management highlighted ongoing challenges but expressed confidence in long-term growth.

They noted that demand for their products remains strong despite market fluctuations.

Lemaitre Vascular Misses on EPS, Stock Up 2.48%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Misses on EPS, Stock Up 2.48%

Key numbers

Management commentary